Illumina and Pillar Biosciences, Inc. today announced an agreement to develop next-generation sequencing (NGS) based in vitro diagnostic (IVD) tests. Under the terms of the agreement, Pillar Biosciences will lead the development of a series of diagnostic tests that will be run on the Illumina MiSeq™Dx instrument. Pillar Biosciences has developed Stem Loop Inhibition Mediated […]
PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise. BG Jones has been named Senior Vice President of Business Development and will lead the expansion of PierianDx’s clinical genomics platform into health systems in the U.S. and global markets while cultivating partner […]
Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. Ms. Eade is Director, M&A Law and Transactions at Corning. Prior to […]
AMSBIO announces the launch of a new service for synthesis of custom-designed, highly modified mRNAs prepared by an advantageous in vitro transcription methodology. Traditional approaches for engineering changes in cellular expression profiles have employed mostly DNA or RNA based viral and non-viral vectors. Unfortunately, these methods carry high risks, due to genomic integration with permanent […]
Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR First patent allowance for MilliporeSigma’s CRISPR technology in North America Related patent application awards by European and Australian Patent Offices already received; similar patents pending elsewhere Burlington, Massachusetts — MilliporeSigma today announced that the Canadian Patent Office has issued […]
Beijing Grandomics using Bionano Saphyr to find Complex Genome Variants in Clincial Applications BEIJING and ORLANDO, Fla. — At the 2017 annual meeting of the American Society of Human Genetics in Orlando, Depeng Wang, the Chief Executive Officer of Beijing Grandomics announced the company’s intent to develop novel assays for genetic diseases in China using […]
Redwood City, California – Synthego, a leading provider of genome engineering solutions, announces the launch of its new CRISPRevolution™ Gene Knockout Kit (GKO) with the first guaranteed CRISPR gene editing solution. The GKO guarantee puts high-quality gene editing results within reach of all CRISPR researchers, including those developing emerging therapeutic modalities with increasing genome engineering demands such as CAR-T […]
ORLANDO, Fla. — The Children’s Hospital of Philadelphia (CHOP) and Edico Genome today set a new scientific world standard in rapidly processing whole human genomes into data files useable for researchers aiming to bring precision medicine into mainstream clinical practice. Utilizing Edico Genome’s DRAGENTM Genome Pipeline, deployed on 1,000 Amazon EC2 F1 instances on the Amazon Web Services (AWS) […]
SANTA CLARA, Calif. — Thermo Fisher Scientific today announced the commercial launch of the Applied Biosystems Axiom Africa Array for medical and population genomics to accelerate and support initiatives in global health and population research. The Wellcome Trust Sanger Institute and Thermo Fisher Scientific combined their respective expertise in human genomic analysis and informatics to co-develop the […]
– Company’s Carlsbad manufacturing facility passes FDA and EMA inspections – Underscores capabilities as commercial manufacturer of viral and gene therapy products Viruses can be used in gene therapy applications to transfer therapeutic genes – Highlights position as leading contract manufacturing organization (CMO) for production of next-generation gene therapies BURLINGTON, Mass. — MilliporeSigma today announced that its Carlsbad, California-based […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
